Role of Non-Albicans Candida and Candida Albicans in Oral Squamous Cell Cancer Patients

被引:35
|
作者
Makinen, Anna [1 ,2 ]
Nawaz, Ali [1 ]
Makitie, Antti [2 ,3 ,4 ,5 ]
Meurman, Jukka H. [1 ,2 ]
机构
[1] Univ Helsinki, Dept Oral & Maxillofacial Dis, Haartmaninkatu 8, FI-00014 Helsinki, Finland
[2] Helsinki Univ Hosp, Helsinki, Finland
[3] Univ Helsinki, Dept Otorhinolaryngol Head & Neck Surg, Helsinki, Finland
[4] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Ear Nose & Throat Dis, Stockholm, Sweden
[5] Karolinska Hosp, Stockholm, Sweden
关键词
SEDATIVE LOAD; RISK; CONSUMPTION; CARCINOMA; OLDER;
D O I
10.1016/j.joms.2018.06.012
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Purpose: This study examined the prevalence of Candida species in the saliva of oral squamous cell carcinoma patients and its effect on the mortality rate. Materials and Methods: One hundred patients with oral cavity squamous cell carcinoma undergoing protocol treatment at Helsinki University Hospital were recruited into the study from March 2011 through 2014. For comparison, 75 age-matched controls with no current or previously treated oral cancer were recruited. Paraffin-stimulated whole saliva samples were collected and cultivated on CHROMagar Candida medium (CHROMagar, Paris, France) to establish possible Candida growth. The API ID 32C yeast identification kit (bioMerieux, Lyon, France) and Bichro-Dubli Fumouze latex agglutination test (Fumouze Diagnostics, Levallois-Perret, France) were used for further identification of different Candida species. Patients' medical records were studied for information on their health habits and general health status, as well as tumor-related data. The patients' status regarding being alive and cancer free was checked at a follow-up point in December 2017. Descriptive statistics and cross tabulation were carried out, and the P value was set at .05. Results: Candida species were detected in 74% of the oral cancer patients' samples, with C. albicans being the most common species (84%). Other species identified were C. dubliniensis (8%), C. tropicalis (4%), C. glabrata (3%), C. parapsilosis (3%), C. sake (3%), C. krusei (1%), and C. guilliermondii (1%). After the follow-up period, 63% of the patients were alive and 86% of them were cancer free. Harboring Candida species in the saliva was not associated with any increase in the mortality rate. Conclusions: C. albicans was common in the oral cavity of the oral squamous cell carcinoma patients. However, in this patient population, we did not observe a statistically significant effect of the yeast on the mortality rate. (C) 2018 American Association of Oral and Maxillofacial Surgeons
引用
下载
收藏
页码:2564 / 2571
页数:8
相关论文
共 50 条
  • [31] Marine bacterial DNase curtails virulence and disrupts biofilms of Candida albicans and non-albicans Candida species
    Banu, Sanaulla Farisa
    Thamotharan, Subbiah
    Gowrishankar, Shanmugaraj
    Pandian, Shunmugiah Karutha
    Nithyanand, Paramasivam
    BIOFOULING, 2019, 35 (09) : 975 - 985
  • [32] Comparison of the clinical risk factors between Candida albicans and Candida non-albicans species for bloodstream infection
    Shigemura, Katsumi
    Osawa, Kayo
    Jikimoto, Takumi
    Yoshida, Hiroyuki
    Hayama, Brian
    Ohji, Goh
    Iwata, Kentaro
    Fujisawa, Masato
    Arakawa, Soichi
    JOURNAL OF ANTIBIOTICS, 2014, 67 (04): : 311 - 314
  • [33] Prevalence of Candida albicans and carriage of Candida non-albicans in the saliva of preschool children, according to their caries status
    Lozano Moraga, Carla Paola
    Rodriguez Martinez, Gonzalo Andres
    Lefimil Puente, Claudia Andrea
    Morales Bozo, Irene Cecilia
    Urzua Orellana, Blanca Regina
    ACTA ODONTOLOGICA SCANDINAVICA, 2017, 75 (01) : 30 - 35
  • [34] Filamentous Non-albicans Candida Species Adhere to Candida albicans and Benefit From Dual Biofilm Growth
    Pathirana, Ruvini U.
    McCall, Andrew D.
    Norris, Hannah L.
    Edgerton, Mira
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [35] Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients
    Vandijck, Dominique M.
    Blot, S.
    Decruyenaere, J.
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (11) : 1916 - 1917
  • [36] CANDIDA ALBICANS AND NON-ALBICANS BLOODSTREAM INFECTIONS IN ADULT AND PEDIATRIC PATIENTS COMPARISON OF MORTALITY AND COSTS
    Moran, Cassandra
    Grussemeyer, Chelsea A.
    Spalding, James R.
    Benjamin, Daniel K., Jr.
    Reed, Shelby D.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (05) : 433 - 435
  • [37] Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients
    Davis, Susan L.
    Vazquez, Jose A.
    McKinnon, Peggy S.
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (04) : 568 - 573
  • [38] Treatment of vaginitis caused by non-albicans Candida species
    Sobel, Jack D.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (05) : 289 - 296
  • [39] Non-albicans Candida species in blood stream infections
    Cetin, C. B.
    Senol, S.
    Degerli, K.
    Tunger, O.
    MYCOSES, 2013, 56 : 102 - 102
  • [40] Proteolytic activity and cytokine up-regulation by non-albicans Candida albicans
    Nawaz, Ali
    Parnanen, Pirjo
    Kari, Kirsti
    Meurman, Jukka H.
    ARCHIVES OF MICROBIOLOGY, 2015, 197 (04) : 533 - 537